PPT-Medication Treatment for Opioid Use Disorder

Brian Grahan MD PhD Addiction Medicine Internal Medicine 672018 Disclosures This educational initiative is funded by a grant from the Minnesota Department of Human Services I have no financial interests to disclose . John Arthur Muenz, Jr., M.D., FAAPM&R, FABAM, FAAFP. Family Care Partners. jmuenz@familycarepartners.com. Disclosure. I have no actual or potential conflict of interest in relation to this . program/presentation.. John e lopes . j. r. .. , . dhs. c. , pa-c. A. ssociate Professor, . Physician Assistant Program. Central Michigan University. and . Project Director. Medication-assisted Treatment Waiver Training Initiative. IN ARMS September 26, 2016. Prepared by. Leslie . Hulvershorn. , MD. Medical Director,. . Division of Mental Health and . Addiction, FSSA. Leslie.Hulvershorn@fssa.IN.gov. Presented by. Dennis Ailes, MA. Wilma Townsend. DPT, Team Leader. November 20, 2014. Objectives. (. 1) increase the field’s knowledge of medication units and their usefulness and barriers to implementation; . (. 2) demonstrate how medication units increase treatment capacity and access to care, . Wilma Townsend. DPT, Team Leader. November 20, 2014. Objectives. (. 1) increase the field’s knowledge of medication units and their usefulness and barriers to implementation; . (. 2) demonstrate how medication units increase treatment capacity and access to care, . Fighting the Stigma. Jeffrey Quamme . Executive Director, Connecticut Certification Board. 2018 UVU Conference. Orem, Utah. Our Goals For Today. Understand the history of MAT for Opioid Use Disorders. The Role of Opioid Medication in Chronic Pain Management Lorraine Widdall, MS APRN BC Interventional Spine and Pain Center Effective December 15, 2013 Emergency rule that temporarily adds provisions under P.L. 185-2013 (SEA246) regarding physicians prescribing opioids for chronic pain. (FORE), a private, national organizationfocused on contributing sustainable and scalable solutions to the opioid crisis, today announced that it is making$10million in grants toorganizations across th Opioid use disorder (OUD) is a complex issue that can occur at any time in one’s life and presents differently for everyone. If you suspect that your patient may be at risk of struggling with OUD, Joshua Blum MD. April 7, 2018. No relevant financial disclosures. Learning objectives. Utilize the latest evidence around opioid-induced hyperalgesia to mitigate negative consequences . Implement best practices around opioid rotation to manage OIH. : . Addressing Fear and Discrimination (Part I). Sharon Morello RN, BSN . Opioid Epidemic and Substance Use Disorders. . Heroin use climbed then stabilized . See table 7.2 in the 2017 NSDUH detailed tables for additional information and the 2017 CDC Mortality Data.. www.hivguidelines.org. JANUARY 2021. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. Increase the number of clinicians in outpatient settings offering evidence-based treatment to individuals with opioid use disorder.. Breaking the Stigma. Christie Simons, MAMFT, LPCA, LCAS-A. Director of Counselor Services, Belmont Abbey College . McLeod Addictive Disease Center . Medication-Assisted Treatment. Introduction . Common Myths?. Providing Compassionate care. Grace Katie Bell MSN RN CARN PHN. Chapa-De Medication Assisted Treatment –one program, two sites. Our Team. Annie . Mascorro. – RN Case Manager . Auburn. Katie Bell - RN Case Manager .